Emergence of the plasmid-mediated quinolone resistance gene qnrS1 in Escherichia coli isolates in Greece

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 8, 2008, Pages 2996-2997

  Vasilaki, Olga ^a   Ntokou, Eleni ^b   Ikonomidis, Alexandres ^b   Sofianou, Danae ^c   Frantzidou, Filanthi ^a   Alexiou Daniel, Styliani ^a   Maniatis, Antonios N ^b   Pournaras, Spyros ^b  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^c Aristotle University of Thessaloniki   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; GENOMIC DNA; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIMENTIN;

AGAR DILUTION; ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; GREECE; HOSPITAL; HUMAN; LETTER; MOLECULAR SIZE; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; QNRS1 GENE;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GREECE; HUMANS; MICROBIAL SENSITIVITY TESTS; PLASMIDS; QUINOLINES;

EID: 48749116553     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00325-08     Document Type: Letter

References (9)

1. Chaniotaki, S., P. Giakouppi, L. S. Tzouvelekis, D. Panagiotakos, M. Kozanitou, G. Petrikkos, A. Avlami, the WHONET Study Group, and A. C. Vatopoulos. 2004. Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in Greece. Clin. Microbiol. Infect. 10:75-78.
2. Chenia, H. Y., B. Pillay, and D. Pillay. 2006. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens. J. Antimicrob. Chemother. 58:1274-1278.
3. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing: 15th informational supplement. M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Hopkins, K. L., M. Day, and E. J. Threlfall. 2008. Plasmid-mediated quinolone resistance in Salmonella enterica, United Kingdom. Emerg. Infect. Dis. 14:340-342.
5. Jacoby, G., V. Cattoir, D. Hooper, L. Martínez-Martínez, P. Nordmann, A. Pascual, L. Poirel, and M. Wang. 2008. qnr gene nomenclature. Antimicrob. Agents Chemother. 52:2297-2299.
6. Jacoby, G. A. 2005. Mechanisms of resistance to quinolones. Clin. Infect. Dis. 41(Suppl. 2):S120-S126.
7. Poirel, L., C. Leviandier, and P. Nordmann. 2006. Prevalence and genetic analysis of plasmid-mediated quinolone resistance determinants QnrA and QnrS in Enterobacteriaceae isolates from a French University Hospital. Antimicrob. Agents Chemother. 50:3992-3997.
8. VIM-endemicity. J. Antimicrob. Chemother. 56:761-764.
9. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.